Association of Human
Patients with a history of myocardial infarction, myocarditis or cardiomyopathy were excluded. Patients with long-QT syndrome or Brugada syndrome were not included in this study. 17, 18 None had a familial arrhythmia history. One hundred and 3 age-and sex-matched healthy subjects were served as controls (control group), of whom 60 were males (mean age, 52±6 years) and 43 were females (mean age, 51±5 years). None had history of syncope and arrhythmia, ECG, echocardiographic findings, and biochemical and hematological tests were strictly normal.
The study protocol was approved by the hospital Ethics Committees, and written informed consent was obtained from all IVA patients and healthy subjects.
Genetic Analysis
Genomic DNA was extracted from peripheral blood leucocytes by standard phenol-chloroform extraction. Previously designed primers 2 were used to amplify exons 2-28 of SCN5A by polymerase chain reaction (PCR). Exon 1 of SCN5A was highly G/C-rich, and primers for cycle sequencing into intron 1 failed to work. One pair of primers for exon 17 were redesigned and synthesized by PRIMERexpress2.0 software for failing to work. The sequences of the resynthesized primers for exon 17 were: forward 5'-CGACAGGT-CCTGAATCTCTTCC-3', reverse 5'-TACCCCTACCCA-CTGCCAAG-3'. Each exon was amplified by Taq DNA polymerase (2 units) using the appropriate set of primers (0.15 ng) and genomic DNA (200 ng). PCR conditions were: denaturation at 94°C for 5 min, followed by 35 cycles of denaturation at 94°C for 1 min, annealing for 1 min, extension at 72°C for 1.5 min, and a final extension at 72°C for 5 min. The PCR products were purified using DNA purification kit, and were directly sequenced on both strands by ABI Prism 3700 DNA Analyzer (Applied Biosystems).The primers used to amplify each exon were also used for sequencing. The novel variations were confirmed by repeat PCR on the genomic DNA and sequencing the subsequent PCR products.
Genomic and cDNA sequences of SCN5A were obtained from GenBank (GenBank accession numbers NT022517. 16 and NM198056.1, respectively). The genomic organization of SCN5A was deduced by comparing the cDNA with the genomic sequence. A glutamine residue at codon 1077 was numbered as the first amino acid residue of exon 18 according to NM198056.1, because all subjects in this study were detected 1077Q at exon 18.
Statistical Analysis
Statistical analysis was done with SPSS 11.5. Comparison of the numeric variables and frequencies between the groups was performed using Student's unpaired t-test and 2 -test or Fisher's exact test, as appropriate. SNP frequencies in both groups were assessed for deviation from Hardy -Weinberg equilibrium (HWE) using the 2 -test. Using PHASE 2.1.1 software (http://www.stat.washington. edu/stephens/) to estimate haplotype frequencies and examine the differences in the overall haplotype frequency profile between the patients and controls. A p-value of <0.05 was considered statistically significant.
Results

SCN5A Variations in Normal Controls
After sequencing SCN5A exons (exons 2-28) and their intron -exon boundaries and 3'-UTR, 11 genetic variations were found; 5 were located in the coding exons (3 synonymous and 2 non-synonymous), 1 in the introns, and 5 in the 3'-UTR ( Table 2) .
Comparison of SNPs Between IVA Patients and Healthy Controls
For females, the allele frequency of c.87G>A was higher in patients with IVA than in controls (0.455 vs 0.198, p= 0.013, odds ratio (OR) 3.382, [95% confidence interval (CI)] 1.253-9.129), whereas for males, the prevalence of minor allele (c.1673A>G) was significantly lower in patients with IVA patients compared with controls (0.025 vs 0.175, p= 0.017, OR 0.121, [95% CI] 0.016-0.930) ( Table 2) . Significant difference existed in occurrence of ventricular arrhythmias between female subjects with 87GA/AA and those with 87GG genotypes (0.348 vs 0.097, p=0.039, OR 4.978) and between male subjects with 1673AA and those with 1673AG/GG genotypes (0.311 vs 0.053, p=0.031, OR 8.143) ( Table 3) .
There were no significant differences in the other 7 SNP (c.4299+53T>C, c.3183A>G, c.5457T>C, c.6174A>G, c.6804C>T, c.7013T>A and c.7014C>T) between patients with IVA and healthy controls (Table 1 ). In addition, the gender did not influence the allele frequencies in either group (data not shown).
Haplotypes and Their Relations to Arrhythmogenesis
To assess the association between the haplotypes of SCN5A and IVA, we determined permutation and estimated frequency of haplotype using software package PHASE 2.1.1. Six haplotypes were evaluated after excluding 3 nonsignificant SNP (Table 4 (Table 5 ). The haplotype AG (87A-1673G) was rare in both IVA patients and controls. Tables 1,3 . 
EPS, electrophysiological; LBBB, left bundle branch block; Lower A, lower axis; RBBB, right bundle branch block; LAH, left anterior hemi-block; LV, left ventricular; RVOT, right ventricle outflow tract. Other abbreviations see in
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The global permutation test revealed a significant difference in distribution of the haplotypes between the groups (p= 0.010). (Table 6 , female patients) and c.1673A>G (Table 7 , male patients) were characterized to explore relationship between SCN5A SNP and phenotype. The clinical features of patients were described in Table 3 , according to genotypes of c.87G>A in women and c.1673A>G in men. No obvious difference in QTc and RR interval was noted among genotypes of c.87G>A in the female patients (Table 6 ) and the whole patients. Because of extremely lower frequency of 1673G (Table 2) , comparison of QTc, RR interval and QRS pattern was not able to be done among genotypes of c.1673A>G in the male patients (Table 7 ) and the patient group.
Discussion
Idiopathic ventricular tachycardia is an uncommon form of ventricular tachycardia that is seen in patients without structural heart disease. 19, 20 This case-control study investigated the association between IVA and SCN5A SNPs, in which overall 11 genetic variations including 5 novel and 6 previously identified ones were detected in 31 unrelated Chinese patients with IVA and 103 healthy controls. The study showed significant difference in distribution of c.87G>A and c.1673A>G between men and women in healthy subjects. The allele frequency of 87A was significant higher in female patients with IVA than in female controls (0.455 vs 0.198, p=0.013), whereas the allele frequency of 1673G (558R) was significantly lower in male patients with IVA than in male controls (0.025 vs 0.175, p=0.017). This suggests that the 87A allele might be associated with an increased risk of IVA in women, whereas the 1673G allele could be positively selected because of its protective effect against ventricular arrhythmia in men.
Since the first report of SCN5A mutations as a cause of LQT-3, 3 various genetic alterations in SCN5A have been suggested to influence the pathophysiology of cardiac arrhythmias. These sodium channelopathies play a critical role in the pathogenesis of Brugada syndrome, 4 idiopathic ventricular fibrillation, 5 sudden infant death syndrome, 6 cardiac conduction defects, 7 congenital sick sinus syndrome, 8 atrial fibrillation 9 and overlapping syndrome. 10 Moreover, such genetic variations seem to modify responses to antiarrhythmic drug therapies, and to certain extent, to sensitize patients to the pro-arrhythmic effects of Na + channelblocking anti-arrhythmic agents. 15 It has been shown that even common polymorphisms in SCN5A can also cause phenotypic variability of these channelopathies. Previous studies have reported that p.His558Arg restored Na + channel function by counteracting the gating or trafficking defects induced by other variations (p.Thr512Ile, p.Met1766Leu and p.Arg282His). [13] [14] [15] In contrast, p.Ser1102Tyr, which is found in 13% of black Americans, was first reported to be a risk factor for arrhythmia. 16 Burke and colleagues found that Y1102 allele was a risk factor in blacks for sudden cardiac death in the absence of obvious morphological cardiac changes or mild to moderate cardiomegaly. 21 Recently, Plant et al demonstrated that infants with 2 copies of S1103Y had a 24-fold increased risk for sudden infant death syndrome. 22 Therefore, genetic variations, including common polymorphisms of SCN5A, affect cardiac electrophysiological properties in a wide range of arrhythmias.
Our results have indicated that 87A was associated with an increased risk of IVA in women, and patients with genotypes 87GA/AA had a 5-fold increased risk of IVA than those with genotype 87GG. Although c.87G>A (p.Ala29Ala) was a synonymous cSNP, its effects on space structure of Na + channel protein remains unknown. We hypothesized that it may be linked with an unidentified variation influencing susceptibility to cardiac arrhythmias, however, further studies are needed to examine if 87A or a 87A-containing haplotype increases the risk for IVA in women.
The p.His558Arg is a well-known non-synonymous SNP located in the Na + channel I-II interdomain cytoplasmic linker. Yang et al have detected p.His558Arg at similar allele frequencies of 0.19-0.24 in patients with drugassociated LQT syndrome and in populations in Tennessee and across the USA. 23 The frequencies were reported to be 0.103-0.132 for healthy Japanese subjects by Takahata et al 24 and Maekawa et al. 25 Furthermore, Maekawa et al also observed a slight decrease in the allele frequencies of p.His558Arg (0.072) and haplotype GG (558Arg-1988Arg) (0.003 vs 0.024 in controls) in arrhythmic patients. In our study, the allele frequency of p.His558Arg in IVA patients (0.048) was reduced compared to healthy controls (0.131), although it did not reach statistical significance level (p= 0.070). However, for men, the allele frequency of 1673G (558R) was significantly lower in patients with IVA than in controls (0.025 vs 0.175, p=0.017). Moreover, males with genotype 1673AG/GG had only a 0.1-fold increased risk of IVA than those with genotype 1673AA. For consistencency with this result, haplotype analysis showed significantly lower frequency of haplotype GG (87G-1673G) in the IVA patients vs the controls (p=0.009), and the frequency of haplotype AATTACTC [87A-1673A-(4299+53)T-5457T-6174A-6804C-7013T-7014C] was obviously higher in the IVA patients than in the controls (p=0.022). These findings suggest that haplotype AATTACTC might play a potential role in the mechanism of pathogenesis of IVA.
Although distinct mechanism for gender difference in relation between SNP c.87G>A, c.1673A>G and IVT remains unknown in our study, previous researches have shown sex-related differences in clinical manifestations in patients with congenital long-QT syndrome, 26, 27 which could be caused by mutations in SCN5A. Shimizu et al also unraveled the association between elevated testosterone concentration and phenotype including male predominance in Brugada syndrome, 28 and both Brugada patients with and without SCN5A mutations displayed a male predominance. 29 Our study noted gender-related difference in distribution of A1673G polymorphism in IVA patients. The reason for this could possibly be a result of positive selection of 1673G allele because of its protective effect against ventricular arrhythmia in the Chinese Han population, especially for males. Unfortunately, we did not have data regarding precipitating factors, such as hormones and metabolic factors, necessary for further elucidation. Experiments has showed that p.His558Arg modulates functional changes of the Na + channel caused by other variations, and plays a role in intragenic complementation, although this common variation per se does not alter the voltage dependence of activa-tion and inactivation kinetics of wild-type channels. 14 Taken together, A1673G polymorphism appears to be protective against ventricular arrhythmia in males, and further studies with large samples are needed to test this hypothesis.
In addition, 2 novel variations c.1676C>T (p.Thr559Ile) and c.6210C>T were detected heterozygous only in 2 different healthy controls (allele frequency 0.005), but not in patients with IVA. Because the healthy individuals who carry these SNP did not show symptoms of arrhythmias, so no evidence was there indicating these SNP unlikely affecting Na + channel function. However, it has been suggested that some variations in SCN5A might increase the risk of acquired long QT syndrome triggered by drug administration in healthy individuals, who are clinically asymptomatic and have normal QT intervals under certain circumstances. 17 Therefore, the possibility cannot be excluded that these 2 novel variations in healthy controls influence the susceptibility to cardiac ion channel blockade and QT prolongation. In future, studies on the electrophysiological properties of the novel variations using heterologous expression systems would further elucidate the importance of these variable sites in Na + channel function.
The present study has several limitations. First, this is in fact a retrospective study and the sample size in the IVA group was relatively small. Comparison between parameters could not reach strict, statistically significant level (p<0.001). Further study is required to increase sample size to ascertain the association of 2 SCN5A SNP c.87G>A and c.1673A>G with IVA. Second, we only assess SCN5A, whether the genetic variations of other ion channels, such as potassium channels (KCNQ1, KCNE1, KCNE2, KCNH2 and KCNJ2) and calcium channel (RyR2), play a role in the development of IVA is still unknown. Finally, because only 1 out of 20 male IVA patients carried genotype 1673AG and only 3 out of 11 female IVA patients carry genotype 87GG, we could not identify the genotype-phenotype correlations in patients with IVA. Follow-up should be done to demonstrate the association of genetic variations of SCN5A with clinical outcome and disease progression for patients with IVA.
In conclusion, this study indicates that genetic variations of SCN5A are associated with occurrence of IVA in Chinese Han population. These findings provide fundamental information necessary to further elucidate the electrophysiological properties of genetic variations of SCN5A and their effects on channel function and association with cardiac arrhythmias.
